CHILTERNS NEURO CENTRE LIMITEDActive

Company number 02294557Private company limited by guaranteeIncorporated 1988
⚠ Confirmation statement overdue. It was due on 3 Sep 2026.

Key figures

£3,338,711
Net assets 2025

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2025
Filed accounts2025
2025
Turnover1,753,738
Cash at bank and in hand379,375
Total assets3,529,049
Total liabilities190,338
Net assets / total equity3,338,711
Average number of employees29

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The charity provides a range of symptom management therapies and treatments to support people who have been diagnosed with Multiple Sclerosis (MS), Parkinson's Disease (PD) and Stroke survivors to give them better control over their lives. It also aims to provide direct care, support and counselling for patients, their carers and families, all conducted in a welcoming inclusive environment.

As described in the company's latest filed accounts.

Summary: CHILTERNS NEURO CENTRE LIMITED

Company

CHILTERNS NEURO CENTRE LIMITED is a private company limited by guarantee registered with Companies House under company number 02294557. It was incorporated on 9 Sep 1988. Its status is active. The registered office is in Aylesbury (HP22). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Turnover was £1,753,738. Net assets were £3,338,711. Cash at bank and in hand was £379,375. Total assets were £3,529,049 and total liabilities £190,338. The company had an average of 29 employees.

Control and charges

2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 3 Sep 2026.